Biotechnology
RSS Feed

MorphoSys Announces Approval of Tremfya(R) (Guselkumab) in South Korea
4/26/2018 -- 4:30 PM -- MorphoSys AG

Rosetta Genomics Announces Shareholder Approval of Merger with Genoptix
4/26/2018 -- 2:00 PM -- Rosetta Genomics Ltd.

Further MP0250 Clinical Data and Partner Interest Underline Molecular Partners' Continued Progress of Its Proprietary Oncology Compounds
4/26/2018 -- 1:00 AM -- Molecular Partners AG

MorphoSys to Host Q1 2018 Conference Call on May 3, 2018
4/25/2018 -- 10:00 AM -- MorphoSys AG

MorphoSys AG: Updated Corporate Calendar 2018
4/25/2018 -- 9:55 AM -- MorphoSys AG

GoX Studio Introduces GoX Ergo, Wearable Sensors to Improve Worker Wellness and Safety
4/24/2018 -- 11:13 AM -- GoX Studio

MorphoSys Announces Closing of Nasdaq IPO through an ADS Offering and Exercise of the Underwriters' Option to Purchase Additional ADSs, Leading to Total Gross Proceeds of USD 239 million
4/23/2018 -- 4:20 PM -- MorphoSys AG

GoX Studio Partners with Briotix to Improve Worker Wellness Using Wearable Sensors
4/23/2018 -- 1:50 PM -- GoX Studio

Anergis and Mymetics Start Research Collaboration Project on the use of Virosomes for Ultra-Fast Allergy Immunotherapy
4/23/2018 -- 2:00 AM -- Mymetics Corp.

Molecular Partners Presented Preliminary Results from the Ongoing Phase 2 Study of MP0250 at the European Myeloma Network Meeting in Turin
4/21/2018 -- 4:15 AM -- Molecular Partners AG

Professor Chenfeng Ke of Dartmouth College Joins Qrons Scientific Advisory Board
4/20/2018 -- 9:35 AM -- Qrons Inc.

MorphoSys Announces Pricing of Initial Public Offering of American Depositary Shares (ADSs) on Nasdaq
4/18/2018 -- 5:45 PM -- MorphoSys AG

Shareholders of Molecular Partners AG Approve All Board Proposals at the Annual General Meeting - Bill Burns Elected New Chairman
4/18/2018 -- 11:29 AM -- Molecular Partners AG

AYOXXA Launches LUNARIS(TM) Human 12-Plex Th17 Kit Expanding Its Portfolio For Fully Scalable Biomarker Analysis
4/18/2018 -- 3:44 AM -- AYOXXA Biosystems GmbH

MorphoSys Resolves a Capital Increase to Implement the Offering of 8,300,000 American Depositary Shares (ADS) in the United States
4/17/2018 -- 7:40 PM -- MorphoSys AG

Shareholder Meeting Adjourned to April 26, 2018
4/17/2018 -- 12:55 PM -- Rosetta Genomics Ltd.

NeurOp Initiates Phase 1 Clinical Trial of NMDA Receptor Inhibitor NP10679
4/12/2018 -- 10:25 AM -- NeurOp, Inc.

Molecular Partners and AstraZeneca Announce Collaboration on Molecular Partners’ Ongoing Oncology Clinical Study With MP0250 in EGFR-Mutated NSCLC
4/11/2018 -- 1:00 AM -- Molecular Partners AG

Rosetta Announces Resignation of CEO
4/10/2018 -- 4:00 PM -- Rosetta Genomics Ltd.

MorphoSys Nominates New Candidates for Supervisory Board
4/10/2018 -- 10:25 AM -- MorphoSys AG

Action Required Before Potential Bankruptcy
4/10/2018 -- 10:00 AM -- Rosetta Genomics Ltd.

Ad hoc: MorphoSys Announces Launch of American Depositary Shares (ADS) Offering in the United States
4/9/2018 -- 7:50 AM -- MorphoSys AG

MorphoSys Announces Approval of Tremfya(R) (Guselkumab) for the Treatment of Moderate to Severe Forms of Psoriasis and Psoriatic Arthritis in Japan
4/6/2018 -- 2:17 AM -- MorphoSys AG

MorphoSys Announces Approvals for Tremfya(R) (Guselkumab) for the Treatment of Moderate-to-Severe Plaque Psoriasis in Brazil and Australia
4/5/2018 -- 10:30 AM -- MorphoSys AG

Rosetta Genomics Urges Shareholders to Vote FOR the Proposed Merger with Genoptix
4/5/2018 -- 8:30 AM -- Rosetta Genomics Ltd.